
MSF calls for stronger Antimicrobial Resistance response to protect people affected by conflict
In 1 click, help us spread this information :
As the world marks World Antimicrobial Resistance (AMR) Awareness Week, MSF called on governments and funders to recognize the enormous toll that antimicrobial resistance is taking in conflict-affected and humanitarian contexts and act urgently by better equipping communities to prevent, detect, and respond to drug-resistant infections - before, during, and after times of acute crisis. Over two billion people are estimated to live in conflict-affected settings, and, in 2025, forced displacement affected an unprecedented 122 million people.
In specific, at the Fourth Plenary Assembly of the AMR Multi-Stakeholder Partnership Platform held in Rome, Italy this week, MSF asked governments and funders to:
- Invest before crises to fund national AMR plans that strengthen infection prevention and control (IPC), water, sanitation and hygiene (WASH), stewardship and laboratories
- Plan for crises along with affected communities to build AMR into emergency preparedness and adapt national AMR plans in protracted crises, implementing context-specific interventions
- Protect health care to uphold international humanitarian law
- Count everyone to include conflict settings in surveillance and research, and ensure equitable access to antimicrobials and diagnostics
For the people we treat, antimicrobial resistance is not a 2050 projection. It is a newborn with sepsis, or a person with a war wound, whose infection no longer responds to the antibiotics we have,” said Dr Cecilia Ferreyra, infectious diseases specialist and Deputy to the International Medical Secretary of MSF.
“The global fight against antimicrobial resistance will fail if it leaves behind people who are living through conflict and displacement. We are asking governments and donors for dedicated funding and adapted national AMR plans that include people vulnerable to crises from the start. The commitments made here and in the Ministerial Conference in Abuja next month will help decide whether these patients still have medical tools that work.”
The risks and consequences of AMR are especially acute in settings affected by conflict and humanitarian crises, where inadequate WASH measures, poor infection prevention and control, and limited access to microbiology, diagnostic capacity, and appropriate antimicrobials contribute to emergence and spread of drug-resistant infections. Destruction of healthcare facilities and infrastructure for water and sanitation, shortages of healthcare workers, disrupted supply chains, and overcrowded living conditions further compound the AMR crisis.
MSF addresses AMR in more than 20 countries through over 50 projects, focusing on infection prevention and control, antibiotic stewardship, microbiology-based diagnostics, and surveillance. Our teams see the diversity of ways in which crises subject people to risk for and from AMR. From treating patients with severe wounds and drug-resistant infections to caring for children with malnutrition and newborns with sepsis, and people living with HIV who develop opportunistic infections, MSF works to strengthen healthcare workers’ capacity to counter AMR through provision of quality, people-centered care.
Antimicrobial resistance is increasingly becoming a consequence of conflict, displacement and fragile health systems,” said Dr Rupa Kanapathipillai, Antimicrobial Stewardship Lead, MSF Operational Centre Paris.
“In Gaza, facilities designed for 250–300 patients a day received as many as 700, with wound care provided from shared trolleys. In South Sudan, Ethiopia and Nigeria, where displacement, flooding and outbreaks hit already stretched clinics, premature babies with sepsis and severely malnourished children are being treated where our antibiograms show high resistance, even in remote areas. Resistance follows displacement and weak health systems, not just the front line.”
Global initiatives, including the updated Global Action Plan on AMR (adopted in May 2026), the planned launch of the Independent Panel for Evidence for Action against AMR, at the 5th Global High-Level Ministerial Conference on AMR in Abuja, Nigeria (6–8 December 2026), offer important opportunities to accelerate action. These initiatives are particularly crucial in light of recent shocks to global health and humanitarian financing that are taking us backwards rather than ahead.
At the upcoming Ministerial Conference in Nigeria, governments must make concrete commitments and ensure that the Independent Panel on Evidence for Action against AMR will close critical evidence gaps in conflict-affected and humanitarian settings and translating evidence into action,” said Pauline Londeix, Advocacy Advisor, MSF Access.
“Meaningful representation of humanitarian actors, affected communities and low-income countries is also essential to guarantee the Panel’s work responds to the needs of people most at risk.”
Publication of Médecins Sans Frontières, with the contribution of MSF's Operational Research Unit in Luxembourg (LuxOR)
The latest publication of Médecins Sans Frontières (MSF), with the contribution of MSF's Operational Research Unit in Luxembourg (LuxOR), explores how global antimicrobial resistance (AMR) targets can be made more practical and equitable by better measuring antibiotic access, appropriate use, diagnostic capacity, and preparedness in humanitarian settings.
Global AMR targets need complementary, context-specific indicators to make implementation equitable and measurable:
- Complement the 70% Access antibiotic target with measures of appropriate use and reliable access;
- Complement AMR mortality targets with actionable diagnostic milestones;
- Integrate AMR into emergency preparedness, monitored through a specific indicator: define minimum infection prevention and control, diagnostic, and treatment capacities.
Making AMR monitoring more equitable, context-specific, and actionable will be essential to translating global commitments into meaningful impact.
According to one of the authors, Pilar Garcia-Vello, Operational Research Advisor in AMR in LuxOR, "global targets set the direction for tackling antimicrobial resistance, but unless they reflect the realities of the patients and health workers of the most vulnerable settings, we risk missing once again their challenges and progress."